VALARTIN PHARMA LLC has developed and implemented a pharmaceutical quality system, the effectiveness of which is subject to annual analysis by the Company's Management and the definition of further measures to improve its functioning.
The pharmaceutical quality system is aimed at organizing, determining measures, controlling and monitoring compliance with the requirements of the Licensing Conditions for conducting business activities in the production of medicinal products, wholesale and retail trade in medicinal products, import of medicinal products (except for active pharmaceutical ingredients), the requirements of Good GHP practices and ISO standards, as well as its continuous improvement.
The company's management has developed a Quality Policy and defined tasks to achieve the set goals. Responsibility for the proper functioning of the Company's FSS is assigned to the personnel of all business processes involved in the FSS. Coordination of the work of structural units for the proper functioning of the FSN is entrusted to the Quality Management Department, which includes the Quality Assurance Department, the Quality Control Department, and the Validation Department.
The physicochemical laboratory of the Quality Control Department is certified by the State Service of Ukraine for Medicinal Products (certificate of certification No. 403 dated April 19, 2019), which is equipped with modern laboratory equipment.
The enterprise carries out full quality control at all stages of production from raw materials to finished products:
You find yourself in a specialized publication, which is part of the site of Valatin Pharma LLC and is intended for medical institutions and doctors (the “certified medical specialists”) and contains professional specialized information about medicines, including prescription medicines, in particular, about their name, characteristics, methods of application, medicinal properties, possible side effects, possible contraindications, and other professional specialized information.
Information about preparations, including prescription medicines of PJSC Pharmaceutical company Darnitsa, is intended solely for familiarizing and is not a guide for self-diagnosis or treatment.
Can you confirm that you have read this restriction on receiving information and you are a medical professional or doctor?